FindTrial
Sign In

Dihydroartemisinin

DRUG8 trials

Sponsors

Shanghai Zhongshan Hospital, Syamsudin Abdillah,Ph.D, Pharm D, The First Affiliated Hospital with Nanjing Medical University, Shanghai Changzheng Hospital

Conditions

Acne VulgarisInfectionsLocally Advanced Colorectal CancerMAFLDMalariaMalaria, VivaxMalaria,FalciparumMetastatic Colorectal Cancer

Early Phase 1

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
RecruitingNCT07007078
Shanghai Zhongshan HospitalAcne Vulgaris
Start: 2025-06-30End: 2026-12-31Target: 60Updated: 2025-06-05

Phase 1

Dihydroartemisinin for MAFLD
RecruitingNCT07679542
The First Affiliated Hospital with Nanjing Medical UniversityMAFLD
Start: 2026-03-30End: 2026-09-01Target: 30Updated: 2026-07-01

Phase 2

Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency
CompletedNCT05829187
Syamsudin Abdillah,Ph.D, Pharm DUncomplicated Plasmodium Falciparum
Start: 2022-11-01End: 2022-12-31Updated: 2023-05-16
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
CompletedNCT06036030
Syamsudin Abdillah,Ph.D, Pharm DMalaria,Falciparum, Malaria, Vivax, Malaria +3
Start: 2019-01-11End: 2019-04-16Updated: 2023-09-13
Efficacy of Dihydroartemisinin for Treating PCOS
CompletedNCT06417099
Shanghai Zhongshan HospitalPolycystic Ovary Syndrome
Start: 2024-05-24End: 2025-03-30Updated: 2025-04-23
Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
RecruitingNCT06842524
Shanghai Zhongshan HospitalPolycystic Ovary Syndrome (PCOS)
Start: 2025-04-16End: 2026-12-31Target: 150Updated: 2025-04-20
CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal Cancer
Active, not recruitingNCT07801352
Shanghai Changzheng HospitalLocally Advanced Colorectal Cancer, Metastatic Colorectal Cancer
Start: 2024-07-01End: 2028-04-01Updated: 2026-09-03

Phase 4

The Effect of Dihydroartemisinin in PCOS
CompletedNCT05465135
Shanghai Zhongshan HospitalPolycystic Ovary Syndrome
Start: 2022-07-01End: 2023-04-23Updated: 2024-05-17

Related Papers

Dihydroartemisinin for the treatment of polycystic ovary syndrome: study protocol for a multi-centre placebo-controlled randomised clinical trial.
2026-06-19